glp 1 and perimenopause PSA for all the women on GLP-1s hormone replacement therapy (HRT Let's talk about GLP-1 medications

If approved for obesity in April 2026, orforglipron would initially be marketed under a single indication, with the diabetes indication expected to follow approximately 12-18 months later

For patients with high risk of developing NAION (e.g., those with diabetes, hypertension) who are taking GLP-1RAs, ophthalmologists may increase vigilance, she said

It can also be easier for insurance companies to cover bariatric surgery due to it being a one-time, permanent solution for weight loss, rather than an ongoing medication

Akoumianakis I, Zagaliotis A, Konstantaraki M, et al

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

GLP-1 medications can deliver significant weight loss results, but high price tags can make them difficult for many to access or stay on often because of inconsistent or nonexistent insurance coverage